Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026)

Verastem (VSTM) recorded quarterly Total Non-Current Liabilities of $146.0 million in Q1 2026, down 4.93% quarter-over-quarter from $153.6 million in Q4 2025, and up 33.5% on a YoY basis from $109.4 million in Q1 2025.

Verastem (VSTM) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Verastem's Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $146.0 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 33.5% year-over-year to $146.0 million; the TTM figure through Mar 2026 stood at $146.0 million (up 33.5% YoY), while the FY2025 annual figure was $153.6 million, up 112.65% from the prior year.
  • Total Non-Current Liabilities was $146.0 million for Q1 2026 at Verastem, down from $153.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $153.6 million in Q4 2025 to a low of $68.0 million in Q3 2024.
  • Historically, Total Non-Current Liabilities has averaged $114.7 million across 4 years, with a median of $126.7 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities fell 5.21% in 2024, then soared 112.65% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $71.8 million in 2023, then advanced by 0.65% to $72.2 million in 2024, then jumped by 112.65% to $153.6 million in 2025, then retreated by 4.93% to $146.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $146.0 million (Q1 2026), $153.6 million (Q4 2025), and $144.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 146.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 146.03 Mn
Dec 31, 2025 153.60 Mn
Sep 30, 2025 144.09 Mn
Jun 30, 2025 152.66 Mn
Mar 31, 2025 109.39 Mn
Dec 31, 2024 72.23 Mn
Sep 30, 2024 68.02 Mn
Sep 30, 2023 71.76 Mn
Jun 30, 2020 83.29 Mn
Mar 31, 2020 84.30 Mn
Dec 31, 2019 137.00 Mn
Sep 30, 2019 170.21 Mn
Jun 30, 2019 168.73 Mn
Mar 31, 2019 154.41 Mn
Dec 31, 2018 151.81 Mn
Sep 30, 2018 74.98 Mn
Jun 30, 2018 45.65 Mn
Mar 31, 2018 29.76 Mn
Dec 31, 2017 31.96 Mn
Sep 30, 2017 21.95 Mn